Page last updated: 2024-09-04

embusartan and exp3174

embusartan has been researched along with exp3174 in 1 studies

Compound Research Comparison

Studies
(embusartan)
Trials
(embusartan)
Recent Studies (post-2010)
(embusartan)
Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010) (exp3174)
8102362943

Protein Interaction Comparison

ProteinTaxonomyembusartan (IC50)exp3174 (IC50)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0013
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0027
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0036
Type-1 angiotensin II receptorHomo sapiens (human)0.002
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0075
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iouzalen, L; Marche, P; Stepien, O1

Other Studies

1 other study(ies) available for embusartan and exp3174

ArticleYear
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles

1999